Abeona Therapeutics Inc.
NASDAQ: ABEO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Vishwas Seshadri
- Employees
- 136
- Headquarters
- Cleveland, United States
- IPO year
- 1980
- Market cap
- $320.3M
- Website
- https://www.abeonatherapeutics.com
Loading ABEO…
Loading profile data…Frequently asked questions about ABEO
What does Abeona Therapeutics Inc. (ABEO) do?
Abeona Therapeutics Inc. is a biopharmaceutical company in the clinical development stage, focused on creating innovative gene and cell therapies to address severe and uncommon genetic diseases. Its leading program, EB-101, an autologous gene-corrected cell therapy, is presently in a Phase III clinical trial for treating recessive dystrophic epi...
Where does ABEO trade?
Abeona Therapeutics Inc. (ABEO) trades on the NASDAQ Capital Market.
What sector is ABEO in?
Abeona Therapeutics Inc. (ABEO) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Abeona Therapeutics Inc.?
Vishwas Seshadri is the chief executive officer of Abeona Therapeutics Inc. (ABEO).
Where is Abeona Therapeutics Inc. headquartered?
Abeona Therapeutics Inc. is headquartered in United States.
Does ABEO pay a dividend?
Abeona Therapeutics Inc. (ABEO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ABEO go public?
Abeona Therapeutics Inc. (ABEO) completed its initial public offering in 1980.